Paratyphoid hepatitis: an emerging clinical entity.
Po-Ren
PR
Hsueh
Jia-Horng
JH
Kao
Yee-Chun
YC
Chen
Pan-Chyr
PC
Yang
Kwen-Tay
KT
Luh
Tien-Kuei
TK
Wang
Szu-Fong
SF
Lin
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D016470:Bacteremia / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D002681:China / Q000453:epidemiology; D003906:Developing Countries; D019353:Endemic Diseases; D005260:Female; D006505:Hepatitis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D006801:Humans; D015994:Incidence; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010284:Paratyphoid Fever / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D011379:Prognosis; D018570:Risk Assessment; D012482:Salmonella paratyphi A / Q000302:isolation & purification*; D014195:Travel
D000900:Anti-Bacterial Agents